Cargando…
Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes
BACKGROUND: Immune checkpoint proteins play critical functions during the immune response to cancer and have been targeted by immune checkpoint blockade therapy. V‐domain Ig suppressor of T cell activation (VSIR) is one of these immune checkpoint genes and has been investigated extensively in recent...
Autores principales: | Yao, Kevin, Zhou, Emily, Schaafsma, Evelien, Zhang, Baoyi, Cheng, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028170/ https://www.ncbi.nlm.nih.gov/pubmed/36394080 http://dx.doi.org/10.1002/cam4.5409 |
Ejemplares similares
-
Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Abaza, Yasmin, et al.
Publicado: (2022) -
Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Kapoor, Sargam, et al.
Publicado: (2021) -
Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer
por: Yao, Kevin, et al.
Publicado: (2022) -
Acute myeloid leukemia and myelodysplastic syndrome associated with a combination of immune checkpoint inhibitor and platinum‐based chemotherapy
por: Nakatsuru, Kousei, et al.
Publicado: (2023) -
Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)